湖北富邦科技股份有限公司 2023 年度内部控制自我评价报告 湖北富邦科技股份有限公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求（以 下简称"企业内部控制规范体系"），结合湖北富邦科技股份有限公司（以下简称"公 司"）内部控制制度和评价办法，在内部控制日常监督和专项监督的基础上，我们对公 司 2023 年 12 月 31 日（以下简称"内部控制评价报告基准日"）的内部控制有效性进 行了评价。 一、重要声明 根据企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其有效性， 并如实披露内部控制自我评价报告是公司董事会的责任。监事会对董事会建立和实施内 部控制进行监督。经理层负责组织领导企业内部控制的日常运行。 公司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存在任何虚假 记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性承担个别及连 带法律责任。 根据公司非财务报告内部控制重大缺陷认定情况，于内部控制评价报告基准日，公 司未发现非财务报告内部控制重大缺陷。 公司自内部控制评价报告基准日至内部控制评价报告披露日之间未发生影响内部 控制有效性评 ...

Financial Performance - The cash received from sales and services increased by 12.44% to ¥290.13 million compared to ¥258.03 million in the same period last year[7]. - The company's operating revenue for Q1 2024 was CNY 315,727,870.21, representing a 27.84% increase compared to CNY 246,970,635.49 in the same period last year[33]. - Net profit attributable to shareholders was CNY 26,200,443.33, up 37.74% from CNY 19,021,304.50 year-over-year[33]. - The net profit after deducting non-recurring gains and losses was CNY 24,985,469.20, reflecting a 40.55% increase from CNY 17,776,709.47 in the previous year[33]. - The net profit for the current period is CNY 27,150,657.98, an increase from CNY 18,271,887.14 in the previous period, representing a growth of approximately 48.5%[69]. - Operating profit for the current period is CNY 36,518,746.27, compared to CNY 24,134,897.18 in the previous period, indicating a growth of about 51.3%[69]. Cash Flow - The net cash flow from operating activities decreased by 112.80% to -¥1.98 million, down from ¥15.48 million in the previous year, primarily due to increased payments to suppliers and employees[7]. - The net cash flow from operating activities was negative at CNY -1,981,641.03, a decline of 112.80% compared to CNY 15,477,002.35 in the same period last year[33]. - Cash flow from operating activities showed a net outflow of CNY 1,981,641.03, a decline from a net inflow of CNY 15,477,002.35 in the previous period[71]. - Cash inflow from investment activities totaled CNY 85,212,438.09, significantly higher than CNY 25,040,792.95 in the previous period[71]. - The net cash outflow from investment activities was CNY 32,716,224.37, an improvement compared to CNY 54,493,900.64 in the previous period[71]. - The company reported a cash and cash equivalents balance of CNY 253,894,274.56 at the end of the period, up from CNY 239,818,757.74 in the previous period[71]. Investment Activities - Cash received from investment recoveries surged by 240.00% to ¥85.00 million, compared to ¥25.00 million in the same period last year, mainly due to the redemption of financial products[7]. - Investment cash payments rose by 48.41% to ¥111.31 million from ¥75.00 million, attributed to payments for the acquisition of a 15% stake in Holland Novochem B.V.[7]. - The company completed the acquisition of a 15% stake in Holland Novochem B.V., increasing its ownership to 100%[21]. Assets and Liabilities - The company's total assets at the end of the reporting period were CNY 1,882,460,741.83, a decrease of 2.95% from CNY 1,939,726,122.82 at the end of the previous year[33]. - Total liabilities decreased to ¥500,103,586.65 from ¥567,842,096.50, a reduction of approximately 11.9%[49]. - Total equity increased to ¥1,382,357,155.18 from ¥1,371,884,026.32, reflecting a growth of about 0.6%[49]. - The company's financial assets decreased by 100.00% due to the redemption of purchased financial products, dropping from ¥1,005.96 million[17]. - Other current liabilities decreased by 67.08% to ¥33.76 million from ¥102.57 million, mainly due to payments related to the equity acquisition[17]. Expenses - Research and development expenses increased by 71.59% to CNY 1,080.56 million, primarily due to increased material costs for new business development[35]. - The company incurred sales expenses of CNY 12,228,075.71, up from CNY 9,090,228.00, marking an increase of approximately 34.5%[69]. - The company's tax expenses rose to CNY 1,228,170.44 from CNY 696,155.51, reflecting an increase of about 76.5%[69]. Market Strategy and Outlook - The company plans to expand its market presence in Africa and Southeast Asia, contributing to the revenue growth observed in the reporting period[35]. - Future outlook includes continued investment in new product development and technology advancements to drive growth[50]. - The company is exploring potential mergers and acquisitions to enhance its competitive position in the market[50]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,448[8]. - Basic and diluted earnings per share for the quarter were both ¥0.0906, an increase from ¥0.0658 in the same period last year[51]. - Net comprehensive income attributable to the parent company was ¥9,578,274.41, compared to ¥25,002,170.93 in the previous year, indicating a significant decrease[51].

湖北富邦科技股份有限公司 关于 2023 年度募集资金存放与实际使用情况的专项报告 湖北富邦科技股份有限公司 董事会关于 2023 年度募集资金存放与使用 情况的专项报告 根据中国证监会发布的《上市公司监管指引第 2 号——上市公司募集资金管理和使用的 监管要求》（2022 年修订）和深圳证券交易所发布的《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》等有关规定，湖北富邦科技股份有限公司（以下简 称"公司"或"本公司"）董事会编制了截至 2023 年 12 月 31 日止募集资金存放与实际使用 情况的专项报告。 一、募集资金基本情况 经中国证券监督管理委员会于 2018 年 1 月 22 日证监许可 [2018] 44 号文核准，本公司 以 2017 年度权益分派实施完毕后总股本 224,870,098 股为基数测算，按每 10 股配售 3 股的 比例向全体股东配售，拟向原股东配售 67,461,029 股人民币普通股 A 股，本次配股发行价 格为人民币 4.43 元/股，截止 2018 年 6 月 29 日，公司已配售人民币普通股 A 股 66,387,997 股，募集资金总额人 ...

湖北富邦科技股份有限公司 关于 2023 年度利润分配预案的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 湖北富邦科技股份有限公司（以下简称"公司"）于 2024 年 4 月 17 日召开 了第四届董事会第七次会议与第四届监事会第六次会议，分别审议通过了《2023 年度利润分配预案》。本议案尚需提交公司股东大会审议，现将有关情况公告如 下： 一、利润分配预案基本情况 根据中审众环会计师事务所（特殊普通合伙）出具的 2023 年度《审计报告》 （众环审字（2024）0101617 号），公司 2023 年度合并报表归属于母公司的净利 润为人民币 71,548,067.23 元，其中母公司的净利润为人民币 5,800,129.41 元，根 据《中华人民共和国公司法》（以下简称"《公司法》"）及《湖北富邦科技股 份有限公司章程》（以下简称"《公司章程》"）的相关规定，按母公司净利润 的 10%提取法定盈余公积金人民币 580,012.94 元后，减去 2022 年度现金分红 14,452,850.90 元，加上合并报表年初未分配利润 579,783,756.92 ...

湖北富邦科技股份有限公司 独立董事 2023 年度述职报告 各位股东及股东代表： 本人作为湖北富邦科技股份有限公司（下称"公司"或"富邦股份"）第四届董 事会的独立董事，2023 年严格按照《中华人民共和国公司法》《中华人民共和国 证券法》《上市公司治理准则》《上市公司独立董事管理办法》《深圳证券交易 所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等相关法律、法 规、规章和《公司章程》等制度的规定和要求，认真履行了独立董事的职责，充 分发挥独立董事的作用，恪尽职守，勤勉尽责，努力维护公司利益和全体股东特 别是中小股东的合法权益，对有关议案或议题履行了必要的审查程序，现将 2023 年度本人履行独立董事职责的情况述职如下： 一、 独立董事的基本情况 （一）基本情况 叶志彪先生，中国国籍，无境外永久居留权，1958 年生，博士学历。华中农 业大学园艺林学学院教授，园艺植物生物学教育部重点实验室副主任，国家现代 农业产业技术体系大宗蔬菜（分子育种）岗位科学家，中国园艺学会常务理事、 中国园艺学会番茄分会理事长、湖北省园艺学会副理事长。1990.09—1992.05 赴 英国诺丁汉大学进行植物生物技术合 ...

Financial Performance - Hubei Forbon Technology Co., Ltd. reported a net profit of CNY 55 million for the fiscal year 2023, representing a year-on-year increase of 21%[111]. - The company achieved a revenue of CNY 300 million in 2023, reflecting a growth of 15% compared to the previous year[111]. - The company's operating revenue for 2023 reached ¥1,048,531,572.70, representing a 23.72% increase compared to ¥847,519,792.90 in 2022[127]. - The net profit attributable to shareholders for 2023 was ¥71,548,067.23, up 32.86% from ¥53,851,228.64 in 2022[127]. - The net cash flow from operating activities significantly increased by 227.47% to ¥102,009,640.04 in 2023, compared to ¥31,150,630.72 in 2022[127]. - The basic earnings per share for 2023 was ¥0.25, a 31.58% increase from ¥0.19 in 2022[127]. - Total assets at the end of 2023 amounted to ¥1,939,726,122.82, reflecting a 13.75% growth from ¥1,705,232,197.42 at the end of 2022[127]. - The company reported a quarterly revenue of ¥298,086,557.49 in Q4 2023, with a net profit of ¥10,142,780.42 for the same quarter[128]. Dividends and Shareholder Information - The company plans to distribute a cash dividend of 0.60 RMB per 10 shares to all shareholders, based on a total of 289,057,018 shares[3]. - The company reported a total shareholding of 653,000 shares for Chairman Wang Ren, with no changes during the period due to marriage transfer[92]. - Director Fang Shengling increased her shareholding by 7,734,700 shares, bringing her total to 7,766,995 shares before her resignation[92]. - The company has no shareholding changes reported for several directors and independent directors, indicating stable governance[92]. Governance and Management - The board of directors has confirmed the accuracy and completeness of the annual report, ensuring no false statements or omissions[15]. - The company has established a complete governance structure, ensuring independence in asset management, personnel, and financial operations[70]. - The company has a diverse board with members holding significant academic and professional backgrounds, including expertise in economics, agriculture, and technology[88][89][90][91]. - The company is actively involved in digital transformation and organizational restructuring, focusing on business model innovation[93]. - The company has appointed several independent directors with extensive experience in various industries, enhancing its governance structure[93]. - The company’s management team includes professionals with backgrounds in finance, engineering, and digital agriculture, indicating a diverse skill set[99]. - The company is committed to enhancing its financial management and risk control through experienced personnel in key positions[98]. Research and Development - The company aims to leverage CRISPR gene editing technology and other molecular biology methods for continuous R&D and technological innovation in the agricultural biotechnology sector[34]. - The company has established a high-throughput screening platform for soil microorganisms and genomic analysis to support the development of microbial agents and bio-fertilizers[34]. - The company is focusing on the integration of traditional fertilizer sales with soil testing and fertilization technology, aiming for improved agricultural efficiency[133]. - The company has a strong focus on research and development, with several ongoing projects in molecular biology and agricultural technology[96]. - The company is actively involved in research and development of beneficial microorganisms and bio-fertilizer formulations to enhance agricultural productivity[170]. - The company is investing CNY 20 million in R&D for new product development, particularly in biodegradable materials[111]. - The company has developed various patented technologies for fertilizer additives, enhancing product performance and meeting environmental regulations[125]. - The company holds 209 domestic authorized patents and 19 PCT international patents, with one major technological achievement recognized as internationally leading[194]. Market Expansion and Sales Strategy - The company is actively expanding its sales team to target previously untapped markets, focusing on both international and domestic business[34]. - The company is actively expanding its international market presence, establishing direct sales channels with foreign BB fertilizer manufacturers and traders[106]. - Hubei Forbon is focusing on expanding its market presence in Southeast Asia, with plans to enter three new countries by the end of 2024[111]. - The company has established stable partnerships with over 400 fertilizer enterprises globally, enhancing its market presence in East Asia, Southeast Asia, Europe, and North Africa[150]. - The company has a two-tier distribution model through provincial and county-level distributors to enhance market influence and sales volume[106]. - The company’s marketing strategies include participation in exhibitions, seminars, and product promotion events to showcase product effectiveness[106]. Risk Management - The company has outlined potential risks in its operations, emphasizing the importance of investor awareness regarding these risks[16]. - The company faces risks related to high accounts receivable balances due to the cyclical nature of its customers, which may impact cash flow and profitability[45]. - The company is committed to strict accounting policies for bad debt provisions and plans to implement efficient customer management to mitigate risks associated with accounts receivable[45]. - The company is implementing measures to mitigate foreign exchange risks, including shortening quotation cycles and increasing the proportion of direct RMB settlements[58]. Product Development and Innovation - The company has developed a comprehensive range of fertilizer products, including water-soluble fertilizers and microbial fertilizers, to meet diverse customer needs[105]. - The company has successfully developed various value-added fertilizers and soil improvement products, including oxygen-releasing fertilizers and customized fertilizers, aimed at enhancing soil quality and crop yield[161]. - The company is focusing on the development of low-carbon, green, and efficient agricultural additives, aligning with the new development philosophy of "innovation, coordination, green, openness, and sharing"[146]. - The company is leveraging its research platform to develop new products for soil restoration and fertilizer reduction, aiming to enhance agricultural sustainability and food security[161]. - The company is committed to sustainable practices, responding to government initiatives to reduce chemical pesticide usage by 50% by 2030[178]. Strategic Partnerships and Collaborations - The company has established equity cooperation with Kangxin Bio and Xiangyu Bio to introduce microbial agents and biological fertilizers[76]. - The company is collaborating with Professor Chen Sanfeng's team from China Agricultural University on nitrogen-fixing bacteria technology, with significant research results in wheat, corn, and rice[182]. - The company is utilizing partnerships with research institutions to enhance its technological capabilities in agricultural biotechnology[170]. - The company has established long-term partnerships with several universities for collaborative research, further boosting its R&D capabilities[194]. Production Capacity and Operations - The company has a designed production capacity of 23,000 tons per annum for fertilizer anti-caking agents (powder), with a capacity utilization rate of 124.07%[56]. - The company has completed construction of a production line for round granule potassium fertilizer with a designed capacity of 100,000 tons per annum, currently operating at a capacity utilization rate of 28.45%[56]. - The company has a designed production capacity of 90,000 tons per annum for ordinary caramel, with a capacity utilization rate of 62.50%[56]. - The company has a designed production capacity of 4,000 tons per annum for Bacillus thuringiensis, currently operating at a capacity utilization rate of 46.40%[56]. - The company has a designed production capacity of 4,000 tons per annum for Bacillus subtilis, currently operating at a capacity utilization rate of 13.20%[56]. - The company has established three production bases in Hubei, Shandong, and for customized product manufacturing, leveraging its globally leading sand material granulation technology[106]. Digital Transformation - The company is actively involved in digital transformation and organizational restructuring, focusing on business model innovation[93]. - The company has developed a digital water and fertilizer integration system to optimize irrigation and fertilization processes, enhancing agricultural efficiency[198]. - The company has established a soil testing and data analysis service using advanced technologies like Alsys analysis robots and SoilOptix CT scanning vehicles for precise agricultural planning[198]. - The company has implemented a new digital marketing strategy, resulting in a 25% increase in online sales channels[111]. - The company has established the "Tomato Community" e-commerce brand to enhance consumer engagement and accumulate user data for personalized product offerings[183].

审 计 报 告 众环审字（2024）0101617 号 湖北富邦科技股份有限公司全体股东： 一、审计意见 我们审计了湖北富邦科技股份有限公司（以下简称"富邦股份公司"）财务报表，包括 2023 年 12 月 31 日的合并及公司资产负债表，2023 年度的合并及公司利润表、合并及公司 现金流量表、合并及公司股东权益变动表以及相关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的规定编制，公允反映了 富邦股份公司 2023 年 12 月 31 日合并及公司的财务状况以及 2023 年度合并及公司的经营成 果和现金流量。 二、形成审计意见的基础 我们按照中国注册会计师审计准则的规定执行了审计工作。审计报告的"注册会计师对 财务报表审计的责任"部分进一步阐述了我们在这些准则下的责任。按照中国注册会计师职 业道德守则，我们独立于富邦股份公司，并履行了职业道德方面的其他责任。我们相信，我 们获取的审计证据是充分、适当的，为发表审计意见提供了基础。 三、关键审计事项 关键审计事项是我们根据职业判断，认为对本期财务报表审计最为重要的事项。这些事 项的应对以对财务报表整体进行审计并形成审计意见为背景，我 ...

湖北富邦科技股份有限公司 2023 年度董事会工作报告 2023年是全面贯彻落实党的二十大精神的开局之年，机会与挑战并存。回顾 过去一年，从国内看，我国经济波浪式发展、曲折式前进，外需下滑和内需不足 碰头，周期性和结构性问题并存；从国际看，世界经济复苏乏力，地缘政治冲突 加剧，保护主义、单边主义上升，对中国企业国际化发展和全球供应链体系构建 都造成了深远影响。 在这一年，公司上下接续奋斗、砥砺前行，在多个业务方向取得了突破。公 司把握了行业转型升级的机遇，农化助剂在市场开拓方面取得了显著成效；借助 多元化的营销模式，放氧肥料新产品成功打开销路；通过研发创新，完成了基于 场景的生物农业战略布局构建，并加速了数字农业的落地示范。 报告期内，公司实现营业收入104,853.16万元，同比上升23.72%；其中境内 实现营业收入56,479.52万元，同比增长33.93%，占整体营收的比例为53.87%；境 外实现营业收入48,373.64万元，同比增长13.60%，占整体营收的比例为46.13%； 归属于上市公司股东的扣除非经常性损益的净利润为7,095.16万元，同比上升 42.90%；资产总额193,972.6 ...

证券代码：300387 证券简称：富邦股份 公告编号：2024-012 湖北富邦科技股份有限公司 关于确认公司 2023 年度日常关联交易并预计 2024 年度日常关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载，误导性陈述或重大遗漏。 湖北富邦科技股份有限公司（以下简称"公司"）于 2024 年 4 月 17 日召开第 四届董事会第七次会议和第四届监事会第六次会议，分别审议通过了《关于确认 公司 2023 年度日常关联交易并预计 2024 年度日常关联交易的议案》。公司董事 长王仁宗先生、董事宋功武先生、董事王应宗先生作为关联方对本议案回避表决， 其余 4 名非关联董事一致表决审议通过本议案。 公司已事先召开第四届董事会 2024 年第一次独立董事专门会议，全体独立 董事一致同意将本议案提交董事会审议。 鉴于以上情况及日常交易状况，公司对 2023 年度日常关联交易进行确认并 对 2024 年度日常关联交易做出预计，具体情况如下： 一、日常关联交易基本情况 （一）日常关联交易概述 1、基于公司业务发展及日常生产经营需要，2023 年度，公司及其控股子公 司与关联方武汉 ...

长城证券股份有限公司 关于湖北富邦科技股份有限公司 经中国证券监督管理委员会于 2018 年 1 月 22 日下发的证监许可【2018】44 号文核准，公司向截至股权登记日 2018 年 6 月 20 日深圳证券交易所收市后在中 国证券登记结算有限公司深圳分公司登记在册的公司全体股东，按照每股 4.43 元的价格，每 10 股配 3 股的比例进行配售。截至 2018 年 6 月 29 日，公司已配 售 A 股普通股 66,387,997 股，募集资金总额人民币 294,098,826.71 元，扣除各项 发行费用人民币 8,853,716.54 元，实际募集资金净额为人民币 285,245,110.17 元。 上述募集资金已于 2018 年 6 月 29 日由主承销商长城证券划入公司开设的募集资 金专户，并经中审众环会计师事务所（特殊普通合伙）出具的众环验【2018】 010046 号验资报告审验。 截至 2023 年 12 月 31 日，募集资金专户余额为 0.00 元。支付 Holland Novochem B.V（以下简称"荷兰诺唯凯"）第四期股权收购款的 40,826,186.30 元 募集资金，存放 ...